Evidence of increased matrix metalloproteinase-9 concentration in patients following cardiopulmonary bypass

Journal of Extra-Corporeal Technology

Volumn 33, Issue 4, 2001, Pages 218-222

  Steinberg, Jay ^a   Fink, G ^a   Picone, A ^a   Searles, Bruce ^a   Schiller, H ^a   Lee, Hsi Ming ^a   Nieman, G ^a  

^a State University of New York Upstate Medical University: College of Medicine   (United States)

Author keywords

Cardiopulmonary bypass; Lung injury; Matrix metalloproteinase 9

Indexed keywords

GELATINASE B; LEUKOCYTE ELASTASE;

ADULT; AGED; ARTICLE; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LEUKOCYTE ACTIVATION; LUNG INJURY; MALE; PERFUSION; POSTPERFUSION SYNDROME; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 0035707186     PISSN: 00221058     EISSN: 29698960     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Adult respiratory distress syndrome following cardiopulmonary bypass: Incidence and prediction
2. Inflammatory response to cardiopulmonary bypass
3. Organ dysfunction after cardiopulmonary bypass
4. Lung injury and ARDS after cardiopulmonary bypass
5. Inflammatory response to cardiopulmonary bypass
6. Matrix metalloproteinase inhibitor: Differential effects on pulmonary neutrophil and monocyte sequestration following CPB
7. Neutrophil-mediated acute lung injury after extracorporeal perfusion
8. Initiation of white cell activation during CPB: Cytokines and receptors
9. The influence of leukocyte filtration during CPB on postoperative lung function
10. Human neutrophil degranulation during extracorporeal circulation
11. Multiple sequential insults cause postpump syndrome
12. CPB primes polymorphonuclear leukocytes
13. CPB renders patients at risk for multiple organ failure via early neutrophil priming and late neutrophil disability
14. Systemic inflammation induced by CPB: A review of pathogenesis and treatment
15. 7S collagen in BAL fluid of patients with ARDS
16. Serum concentration of 7S collagen and prognosis in patients with ARDS
17. Plasma elastase levels and the development of ARDS
18. Elastase activity in pulmonary lavage fluid from patients with ARDS
19. Acute et al lung injury during CPB
20. Evidence of organ damage after CPB
21. Neutrophil elastase release and CPB
22. Alpha-1 proteinase inhibitor in gingival crevicular fluid of humans with adult periodontitis
23. Higher concentrations of MMP in BAL fluid of patients with ARDS
24. Gelatinases in epithelial lining fluid of patients with ARDS
25. MMP and TIMP in ARDS
26. Purification and characterization of a collagenase extracted from rabbit tumors
27. Cardiopulmonary bypass induces the synthesis and release of matrix metalloproteinases
28. Effect of CPB on systemic release of neutrophil elastase and tumor necrosis factor
29. The inflammatory response and extracorporeal circulation
30. Myeloperoxidase and elastase as markers of leukocyte activation during CPB in humans
31. Protective effects of ONO-5046 Na, a specific neutrophil elastase inhibitor on postperfusion lung injury
32. Neutrophil priming and activation in the pathogenesis of postinjury multiple organ failure
33. Tissue destruction by neutrophils
34. MMP and elastase activity in endotoxin-induced lung injury in guinea pigs
35. MMP inhibitor prevents acute lung injury after CPB
36. Nafomostat mesilate, a broad spectrum protease inhibitor, modulates platelet, neutrophil, and contact activation in simulated extracorporeal circulation
37. A human urinary protease inhibitor inhibits neutrophil extracellular release of elastase during CPB